Search research articles
Contact Us
Filters
Showing results (151-160 of 175) with videos related to
Page
of 18
Sort By:
Cancer
|
March 22, 2012
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study
Susan Urba, Carla M L van Herpen, Tarini Prasad Sahoo, et al.
Head & Neck
|
June 26, 2020
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)
Chia-Jui Yen, Naomi Kiyota, Nobuhiro Hanai, et al.
Journal of Translational Medicine
|
December 22, 2025
EpCAM activates the ERK-EGR1 signaling axis and promotes TNF-α-induced the progression of anaplastic thyroid cancer
Chi-Chiu Lee, Yi-Jen Su, Sushree Shankar Panda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2022
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Tom Wei-Wu Chen, Chia-Lang Hsu, Ruey-Long Hong, et al.
Oral Oncology
|
September 24, 2017
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141
Naomi Kiyota, Yasuhisa Hasegawa, Shunji Takahashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2005
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
Anthony T C Chan, Mow-Ming Hsu, Boon C Goh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2013
An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma
Quynh-Thu Le, Qiang Zhang, Hongbin Cao, et al.
American Journal of Clinical Oncology
|
February 21, 2018
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study
Roger B Cohen, Jean-Pierre Delord, Toshihiko Doi, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
March 23, 2024
Sequential multimodal treatments with chemotherapy and surgery for advanced soft tissue sarcoma may be associated with better survival than chemotherapy
Ching-Tso Chen, Hsing-Wu Chen, Wei-Hsin Lin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 22, 2011
Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: treatment outcomes, marginal misses, and perspective on target delineation
Wan-Yu Chen, Sung-Hsin Kuo, Yu-Hsuan Chen, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 175) with videos related to
Sort By:
Page
of 18
Cancer
|
March 22, 2012
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study
Susan Urba, Carla M L van Herpen, Tarini Prasad Sahoo, et al.
Head & Neck
|
June 26, 2020
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)
Chia-Jui Yen, Naomi Kiyota, Nobuhiro Hanai, et al.
Journal of Translational Medicine
|
December 22, 2025
EpCAM activates the ERK-EGR1 signaling axis and promotes TNF-α-induced the progression of anaplastic thyroid cancer
Chi-Chiu Lee, Yi-Jen Su, Sushree Shankar Panda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2022
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Tom Wei-Wu Chen, Chia-Lang Hsu, Ruey-Long Hong, et al.
Oral Oncology
|
September 24, 2017
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141
Naomi Kiyota, Yasuhisa Hasegawa, Shunji Takahashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2005
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
Anthony T C Chan, Mow-Ming Hsu, Boon C Goh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2013
An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma
Quynh-Thu Le, Qiang Zhang, Hongbin Cao, et al.
American Journal of Clinical Oncology
|
February 21, 2018
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study
Roger B Cohen, Jean-Pierre Delord, Toshihiko Doi, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
March 23, 2024
Sequential multimodal treatments with chemotherapy and surgery for advanced soft tissue sarcoma may be associated with better survival than chemotherapy
Ching-Tso Chen, Hsing-Wu Chen, Wei-Hsin Lin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 22, 2011
Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: treatment outcomes, marginal misses, and perspective on target delineation
Wan-Yu Chen, Sung-Hsin Kuo, Yu-Hsuan Chen, et al.
Page
of 18